[1] VASILE R G，BRUCE S E，GOISMAN R M，et al.Results of a naturalistic longitudinal study of benzodiazepine and SSRI use in the treatment of generalized anxiety disorder and social phobia[J] . Depress Anxiety，2005，22(2)：59-67. [2] RICKELS K，ZANINELLI R，MCCAFFERTY J，et al. Paroxetine treatment of generalized anxiety disorder： a double-blind，placebo-controlled study[J] . Am J Psychiatry，2003，160(4)：749-756. [3] STOCCHI F，NORDERA G，JOKINEN R，et al. Efficacy and tolerability of paroxetine for the long-term treatment of GAD.In： New Research Abtracts of the 154th Annual Meeting of the American Psychiatric Association[C] .New Orleans，May 9，2001，La.Abstract NR633：171. [4] VARIA I，RAUSCHER F.Treatment of generalized anxiety disorder with citalopram[J] . Int Clin Psychopharmacol，2002，17(3)：103-107. [5] BIELSKI R J，BOSE A，CHANG C C.A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder[J] . Ann Clin Psychiatry，2005，17(2)：65-69. [6] BALL S G，KUHN A，WALL D，et al.Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder： a double-blind，prospective comparison between paroxetine and sertraline[J] . J Clin Psychiatry，2005，66(1)：94-99. [7] DAVIDSON J R，DUPONT R L，HEDGES D，et al. Efficacy，safety，and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder[J] . J Clin Psychiatry，1999，60(8)：528-535. [8] MONTGOMERY S A，MAHE V，HAUDIQUET V，et al.Effectiveness of venlafaxine，extended release formulation，in the short-term and long-term treatment for generalized anxiety disorder：results of a survival analysis[J] . J Clin Psychopharmacol，2002，22(6)：561-567. [9] STEIN M B，FYER A J，DAVIDSON J R. Fluvoxamine treatment of social phobia (social anxiety disorder)： a double-blind，placebo-controlled study[J] . Am J Psychiatry，1999 ，156(5)：756-760. [10] The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. Fluvoxamine for the treatment of anxiety disorders in children and adolescents[J] . N Engl J Med，2001，26(17)：1279-1285. [11] LEPOLA U，BERGTHOLDT B，ST LAMBERT J，et al.Controlled-release paroxetine in the treatment of patients with social anxiety disorder[J] . J Clin Psychiatry，2004，65(2)：222-229. [12] SEEDAT S，STEIN M B.Double-blind，placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder[J] . J Clin Psychiatry，2004，65(2)：244-248. [13] VAN AMERINGEN M A，LANE R M，WALKER J R，et al. Sertraline treatment of generalized social phobia： a 20-week，double-blind，placebo-controlled study[J] . Am J Psychiatry，2001，158(2)：275-281. [14] WALKER J R，VAN AMERINGEN M A，SWINSON R，et al. Prevention of relapse in generalized social phobia： results of a 24-week study in responders to 20 weeks of sertraline treatment[J] . J Clin Psychopharmacol，2000，20(6)：636-644. [15] CONNOR K M，DAVIDSON J R，CHUNG H，et al.Multidimensional effects of sertraline in social anxiety disorder[J] . Depress Anxiety，2006，23(1)：6-10. [16] SCHNEIER F R，BLANCO C，CAMPEAS R，et al. Citalopram treatment of social anxiety disorder with comorbid major depression[J] . Depress Anxiety，2003，17(4)：191-196. [17] DAVIDSON J R，FOA E B，HUPPERT J D，et al.Fluoxetine，comprehensive cognitive behavioral therapy，and placebo in generalized social phobia[J] . Arch Gen Psychiatry，2004，61(10)：1005-1013. [18] ALTAMURA A C，PIOLI R，VITTO M，et al. Venlafaxine in social phobia： a study in selective serotonin reuptake inhibitor non-responders[J] . Int Clin Psychopharmacol，1999，14(4)：239-245. [19] VAN VEEN J F，VAN VLIET I M，WESTENBERG H G. Mirtazapine in social anxiety disorder： a pilot study[J] . Int Clin Psychopharmacol，2002，17(6)：315-317. [20] TUCKER P，ZANINELLI R，YEHUDA R，et al.Paroxetine in the treatment of chronic posttraumatic stress disorder： results of a placebo-controlled，flexible-dosage trial[J] . J Clin Psychiatry，2001，62(11)：860-868. [21] DAVIDSON J R，ROTHBAUM B O，VAN DER KOLK B A，et al. Multicenter，double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder[J] . Arch Gen Psychiatry，2001，58(5)：485-492. [22] RAPAPORT M H，ENDICOTT J，CLARY C M. Posttraumatic stress disorder and quality of life： results across 64 weeks of sertraline treatment[J] . J Clin Psychiatry，2002，63(1)：59-65. [23] DAVIDSON J，PEARLSTEIN T，LONDBORG P，et al. Efficacy of sertraline in preventing relapse of posttraumatic stress disorder： results of a 28-week double-blind，placebo-controlled study[J] . Am J Psychiatry，2001，158(12)：1974-1981. [24] MARTENYI F，BROWN E B，ZHANG H，et al. Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder[J] . Br J Psychiatry，2002，181：315-320. [25] ONDER E，TURAL U，AKER T. A comparative study of fluoxetine，moclobemide，and tianeptine in the treatment of posttraumatic stress disorder following an earthquake[J] . Eur Psychiatry，2006，21(3)： 174-179. [26] DAVIS L L，FRAZIER E C，WILLIFORD R B，et al. Long-term pharmacotherapy for post-traumatic stress disorder[J] . CNS Drugs，2006，20(6)：465-476. [27] MARTENYI F，SOLDATENKOVA V.Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder： Analysis of the veteran group of a placebo-controlled，randomized clinical trial[J] . Eur Neuropsychopharmac，2006，16(5)：340-349. [28] ZHAO J P. Clinical Psychopharmacology and Drug Therapy（精神药物治疗学）[M] . Beijing： People's Military Medical Press，2005：299-340. [29] SHEEHAN D V，BURNHAM D B，IYENGAR M K，et al.Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder[J] . J Clin Psychiatry，2005，66(1)：34-40. [30] BERTANI A，PERNA G，MIGLIARESE G，et al. Comparison of the treatment with paroxetine and reboxetine in panic disorder： a randomized，single-blind study[J] . Pharmacopsychiatry，2004，37(5)：206-210. [31] MICHELSON D，ALLGULANDER C，DANTENDORFER K，et al. Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder： randomised，placebo-controlled trial[J] . Br J Psychiatry，2001，179：514-518. [32] RIBEIRO L，BUSNELLO J V，KAUER-SANT'ANNA M，et al. Mirtazapine versus fluoxetine in the treatment of panic disorder[J] . Braz J Med Biol Res，2001，34(10)：1303-1307. [33] ASNIS G M，HAMEEDI F A，GODDARD A W，et al.Fluvoxamine in the treatment of panic disorder： a multi-center，double-blind，placebo-controlled study in outpatients[J] . Psychiatry Res，2001，103(1)：1-14. [34] STAHL S M，GERGEL I，LI D. Escitalopram in the treatment of panic disorder： a randomized，double-blind，placebo-controlled trial[J] . J Clin Psychiatry，2003 ，64(11)：1322-1327. [35] BANDELOW B，BEHNKE K，LENOIR S，et al.Sertraline versus paroxetine in the treatment of panic disorder： an acute，double-blind noninferiority comparison[J] . J Clin Psychiatry，2004 ，65(3)：405-413. [36] BOSHUISEN M L，SLAAP B R，VESTER-BLOKLAND E D，et al. The effect of mirtazapine in panic disorder： an open label pilot study with a single-blind placebo run-in period[J] . Int Clin Psychopharmacol，2001，16(6)：363-368. [37] KAMIJIMA K，MURASAKI M，ASAI M，et al. Paroxetine in the treatment of obsessive-compulsive disorder： randomized，double-blind，placebo-controlled study in Japanese patients[J] . Psychiatry Clin Neuros，2004，58(4)：427-433. [38] MARAZZITI D，GIANNOTTI D，CATENA M C，et al. Insight in body dysmorphic disorder with and without comorbid obsessive-compulsive disorder[J] .CNS Spectr，2006，11(7)：494-498.